Adial Pharmaceuticals, Inc

ADIL XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

5.1M

Short interest (May 15)

3.6%

Net Short (Jun 03 ): -0.2%

Borrow Fee

1.85%

↑ 70.6%

Available Shares

90K

↑ 32.4%

Price Chart

Company Overview

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001513525

Asset Type: CS

Market Data

Market Cap: $5,058,945

Employees: 6

Status: Active

Short Interest

Current Borrow Fee 1.85%

Range: 1.65% - 2.43%

Available Shares 90K

Range: 40K - 90K

Recent Changes

Fee Change: ↓ 10.2%

Available Change: ↑ 3.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime